Bradley Rivotto

Prognostic role of circulating exosomal miRNAs in multiple myeloma

Salomon Manier, Chia‐Jen Liu, Hervé Avet‐Loiseau et al. · Blood · 2017 · 268 citations · Full text

Medicine, Hematology, Oncology +16

A Phase I/II Study of Evofosfamide, A Hypoxia-activated Prodrug with or without Bortezomib in Subjects with Relapsed/Refractory Multiple Myeloma

Jacob P. Laubach, Chia‐Jen Liu, Noopur Raje et al. · Clinical Cancer Research · 2018 · 42 citations · Full text

Medicine, Oncology, Pharmacology +16

Phase II Trial of Combination of Elotuzumab, Lenalidomide, and Dexamethasone in High-Risk Smoldering Multiple Myeloma

Irene M. Ghobrial, Ashraf Badros, James J. Vredenburgh et al. · Blood · 2016 · 34 citations

Medicine, Oncology, Pharmacotherapy +13

Single-Cell RNA Sequencing Reveals Compromised Immune Microenvironment in Precursor Stages of Multiple Myeloma

Oksana Zavidij, Nicholas J. Haradhvala, Tarek H. Mouhieddine et al. · Blood · 2018 · 32 citations

Life Sciences, Immunology, Molecular Biology +17

Phase II Trial of Combination of Elotuzumab, Lenalidomide, and Dexamethasone in High-Risk Smoldering Multiple Myeloma

Chia‐Jen Liu, Irene M. Ghobrial, Mark Bustoros et al. · Blood · 2018 · 25 citations

Medicine, Oncology, Pharmacotherapy +13